A theme the specialists are building · as of 2026-09-19
Rare Disease Innovation
This is an early-stage biotech basket targeting high-value rare and specialized diseases where clinical wins can re-rate platform companies sharply.
6 proven specialist funds in5 stocks in the basket1 Crowded3 Tracked1 Unknown
EDITCrowdedCRISPR therapies for inherited and hematologic disorders — one name revealed, on us
The other 4 names, each with its role and stage, are inside.See the basket — free account →
Themes are read from quarterly filings of proven specialist funds plus the options tape. Evidence, not advice. Track our public record on The Book.